Shared decision making, decision aid, prostate cancer, CRPC
Conditions
Interventions
Decision aid with value clarification exercise
Sponsors
Elisabeth- TweeSteden Ziekenhuis
Postbus 90151
5000 LC Tilburg
Eligibility
Inclusion criteria
Inclusion criteria: - Men that are newly diagnosed with CRPC. CRPC is defined as any cancer progression under maximal hormonal treatment with anti-androgens and/or LHRH agonist or antagonist (when three consecutive rises of PSA are observed at castrate serum levels of testosterone (< 50 ng/dL or <1.7 nmol/L) and/or progression of osseous lesions is shown)) - Patients are eligible for at least two treatment options - Patients have to be able to make use of a computer with internet-access in order to make use of the web-based decision aid - Patients have to be able to complete a Dutch questionnaire
Exclusion criteria
Exclusion criteria: - In the case of a second opinion the patient will not be included if the first opinion was obtained in one of the other involved hospitals and vice versa - Patients who do not have sufficient knowledge of the Dutch language
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| - Objective knowledge - Informed choice | — |
Secondary
| Measure | Time frame |
|---|---|
| - Correlation between G8 score and treatment decision - Correlation between TUG-test and treatment decision - Quality of life - Anxiety - Value clarification - Satisfaction with decision making, information and treatment - Preparation for decision making - Healthcare providers' evaluation of decision aid - Partner involvement in SDM - Treatment outcome (e.g. dose reductions, treatment delays, treatment discontinuation, treatment switch, and death) | — |
Contacts
Public ContactIsabel de Angst
Erasmus MC/Elisabeth- TweeSteden Ziekenhuis, Urologie
Outcome results
None listed